Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical Data

NCT06754865 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

1140

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Xiyanping injection+ antibiotic
DRUG: Antibiotic

Sponsor

Jiangxi Qingfeng Pharmaceutical Co. Ltd.